Advanced search
Publication Cover
OncoTargets and Therapy Volume 14, 2021 - Issue
Submit an article Journal homepage
91
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Screening of Therapeutic Candidate Genes of Quercetin for Cervical Cancer and Analysis of Their Regulatory Network

Yuanyuan Li1 Department of Reproductive Medicine, The First Affiliated Hospital, College of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, People’s Republic of China;2 Scientific Research Department, The Second Affiliated Hospital, Shaanxi University of Chinese Medicine, Xixian New Area, Shaanxi, 712000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-7336-6861View further author information
ORCID Icon,
Jiushe Kou3 Pain Department, The Second Affiliated Hospital, Shaanxi University of Chinese Medicine, Xixian New Area, Shaanxi, 712000, People's Republic of ChinaView further author information
,
Tao Wu4 College of Acupuncture and Massage, Shaanxi University of Chinese Medicine, Xixian New Area, Shaanxi, 712046, People’s Republic of ChinaView further author information
,
Pengsheng Zheng1 Department of Reproductive Medicine, The First Affiliated Hospital, College of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Xu Chao2 Scientific Research Department, The Second Affiliated Hospital, Shaanxi University of Chinese Medicine, Xixian New Area, Shaanxi, 712000, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 857-866 | Published online: 05 Feb 2021

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71. doi:10.1016/j.canlet.2017.04.024
  • Chen W, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2014. Chinese J Cancer Res. 2018;30(1):1–12. doi:10.21147/j.issn.1000-9604.2018.01.01
  • Zheng RT, Sun KT, Zhang ST, et al. Report of cancer epidemiology in China, 2015. Chin J Oncol. 2019;41(1):19–28. doi:10.3760/cma.j.issn.0253-3766.2019.01.005
  • Zhang S, Batur P. Human papillomavirus in 2019: an update on cervical cancer prevention and screening guidelines. Cleve Clin J Med. 2019;86(3):173–178. doi:10.3949/ccjm.86a.18018
  • Jana N, Bretislav G, Pavel S, Pavla U. Potential of the flavonoid quercetin to prevent and treat cancer - current status of research. Klin Onkol. 2018;31(3):184–190. doi:10.14735/amko2018184
  • Clemente-Soto AF, Salas-Vidal E, Milan-Pacheco C, Sanchez-Carranza JN, Peralta-Zaragoza O, Gonzalez-Maya L. Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression-independent manner in HPV-positive human cervical cancer-derived cells. Mol Med Rep. 2019;19(3):2097–2106. doi:10.3892/mmr.2019.9850
  • Zhai Y, Kuick R, Nan B, et al. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res. 2007;67(21):10163–10172. doi:10.1158/0008-5472.CAN-07-2056
  • Scotto L, Narayan G, Nandula SV, et al. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer. 2008;47(9):755–765. doi:10.1002/gcc.20577
  • den Boon JA, Pyeon D, Wang SS, et al. Molecular transitions from papillomavirus infection to cervical precancer and cancer: role of stromal estrogen receptor signaling. Proc Natl Acad Sci U S A. 2015;112(25):E3255–3264. doi:10.1073/pnas.1509322112
  • Wong YF, Selvanayagam ZE, Wei N, et al. Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res. 2003;9(15):5486–5492.
  • Yuan H, Pan Y, Young CY. Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells. Cancer Lett. 2004;213(2):155–163. doi:10.1016/j.canlet.2004.04.003
  • Thomas A, Mahantshetty U, Kannan S, et al. Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease. Cancer Med. 2013;2(6):836–848. doi:10.1002/cam4.152
  • Lv Y, Cang W, Li Q, et al. Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRbeta-IL-6 axis in MUC1-positive cervical cancer. Oncogenesis. 2019;8(12):70. doi:10.1038/s41389-019-0179-2
  • Yan J, Zhang Y, Ren C, Shi W, Chen L. Involvement of nuclear protein C23 in activation of EGFR signaling in cervical cancer. Tumour Biol. 2016;37(1):905–910. doi:10.1007/s13277-015-3889-x
  • Peng Z, Wang Q, Zhang Y, He J, Zheng J. EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients. Int J Oncol. 2016;49(4):1737–1745. doi:10.3892/ijo.2016.3655
  • Offin M, Rizvi H, Tenet M, et al. Tumor mutation burden and efficacy of EGFR-tyrosine kinase inhibitors in patients with EGFR-mutant lung cancers. Clin Cancer Res. 2019;25(3):1063–1069. doi:10.1158/1078-0432.CCR-18-1102
  • Masood A, Kancha RK, Subramanian J. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: focus on afatinib. Semin Oncol. 2019;46(3):271–283. doi:10.1053/j.seminoncol.2019.08.004
  • Chan DLH, Segelov E, Wong RS, et al. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer. Cochrane Database Syst Rev. 2017;6:CD007047. doi:10.1002/14651858.CD007047.pub2
  • Bastos DA, Antonarakis ES. CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer. Expert Rev Mol Diagn. 2018;18(2):155–163. doi:10.1080/14737159.2018.1427068
  • Chopra S, Deodhar K, Pai V, et al. Cancer stem cells, CD44, and outcomes following chemoradiation in locally advanced cervical cancer: results from a prospective study. Int J Radiat Oncol Biol Phys. 2019;103(1):161–168. doi:10.1016/j.ijrobp.2018.09.003

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.